| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.048 | 0.3 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.051 | 0.3 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |